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Xanthine derivatives possess different pharmacological activity. Some of the asym-
metrically substituted xanthines are useful for treating CNS diseases such as Alzhei-
mer’s type dementia (1). For example, a new xanthine derivative, propentophylline, was
recently introduced as a drug with neuroprotective properties for treatment of brain de-
mentia (2), boosting the search for new xanthine derivatives with neuroprotective activ-
ity. Introduction of different substituents on the 8th position in caffeine structure is of
great importance for extending the biological activity spectrum of its derivatives (3).
The synthesis of five new 1,3,7-trimethylxanthine derivatives is reported. Acute
intraperitoneal and peroral toxicity, effect on the locomotor activity and brain asphyctic,
haemic and circulatory antihypoxic activity of compounds are described.
EXPERIMENTAL
Analytical methods
Melting points were determined on an electrothermal apparatus (Büchi 535, Swit-
zerland) in an open capillary tube and are uncorrected. The IR spectra were recorded on
a Shimadzu FTIR 8101M spectrophotometer (Shimadzu, Japan) in nujol. The 1H NMR
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spectra were measured on a Bruker 100 WP (100-MHz) spectrometer (Germany) using
DMSO-d6 as solvent and chemical shifts were expressed as d values in ppm against TMS
as an internal standard. TLC was performed on DC-Alufolien Kieselgel 60 F254, 0.20 mm
(Merck, Germany) sheets with the mobile phase: chloroform/acetone/ethanol (3:3:4, V/V).
The spots were detected at UV 254 nm. All names were generated by using AutoNom
2000 Add-in for MDL ISIS/Draw (4).
Syntheses
Synthesis of 8-bromocaffeine 2 was performed from caffeine and hydrobromic acid
in the presence of hydrogen peroxyde (5).
General method for preparation of (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-
purin-8-ylsulfanyl)-acetamides (5a–e)
Method A. – (1,3,7-Trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-acetic
acid methyl ester 4 (2.99 g, 0.01 mol) and a corresponding amine (0.02 mol) were mixed.
The mixture was heated at 120  C until 4 melted. Thereafter it was heated at the same
temperature for 45–60 minutes. A minimal quantity of ethanol was added to the reaction
mixture after cooling to room temperature. The product crystallized after cooling. The
separated crystals were recrystallized from ethanol.
Method B. – Caffeine-8-thioglycolic acid 3 (3.13 g, 0.011 mol), the corresponding amine
(0.01 mol) and 4-dimethylaminopyridine (DMAP, 0.3 g, 0.0025 mol) were dissolved in
100 mL of anhydrous dimethylformamide at 60 °C. After complete dissolution, dicyclo-
hexylcarbodiimide (DCC, 2.7 g, 0.013 mol) dissolved in 15 mL of anhydrous dimethyl-
formamide was added. The reaction mixture was stirred at room temperature for 24 h
and the white precipitate of N,N-dicyclohexylurea (DCU) was filtered off. After concen-
trating to 1/3 volume of the filtrate on the rotary evaporator, cooled anhydrous ethanol
was added and the solution was kept for about 24 h at –5 °C. The crystals of DCU were
filtered off and the filtrate was evaporated. The residue was crystallized from ethanol.
The separated crystals were washed with petroleum ether and recrystallized from etha-
nol.
N-[2-(3,4-dimethoxyphenyl)-ethyl]-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-pu-
rin-8-ylsulfanyl)-acetamide (5a). – Method A: from 4 and 0.02 mol 2-(3,4-dimethoxyphenyl)-
ethylamine (3.62 g, 3.30 mL); reaction time 1 h. Method B: from 3 and 0.01 mol 2-(3,4-
-dimethoxyphenyl)-ethylamine (1.81 g, 1.70 mL); reaction time 20 h.
N-phenethyl-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-acetamide
(5b). – Method A: from 4 and 0.02 mol phenylethylamine (1.21 g, 2.60 mL); reaction time 1
h. Method B: from 3 and 0.01 mol phenylethylamine (0.61 g, 1.30 mL); reaction time 24 h.
N-(1-methyl-2-phenylethyl)-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl-
sulfanyl)-acetamide (5c). – Method A: from 4 and 0.02 mol 1-methyl-2-phenylethylamine
(1.35 g, 2.50 mL); reaction time 1 h. A minimal quantity of ether was added to the reac-
tion mixture after cooling to room temperature. The separated crystals were recrystal-
lized from ethanol. Method B: from 3 and 0.01 mol 1-methyl-2-phenylethylamine (0.68 g,
1.20 mL); reaction time 24 h.
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N-[2-(4-hydroxyphenyl)-ethyl]-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl
-sulfanyl)-acetamide (5d). – Method A: from 4 and 0.02 mol 4-(2-aminoethyl)-phenol (1.37 g,
2.74 mL); reaction time 45 min. The separated crystals were recrystallized from ethanol/wa-
ter 1:1. The free base of 4-(2-aminoethyl)-phenol was obtained as follows: 4-(2-
aminoethyl)-phenol hydrochloride (0.029 mol, 5.04 g) was dissolved in 10 mL of water un-
der heating and stirring. Sodium carbonate (1.54 g, 0.0145 mol) in 5 mL of water was added
to the hot solution and 4-(2-aminoethyl)-phenol base crystallized after cooling. Method B:
from 3 and 0.01 mol 4-(2-aminoethyl)-phenol (0.70 g, 1.4 mL); reaction time 24 min.
N-(tetrahydrofuran-2-ylmethyl)-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-
ylsulfanyl)-acetamide (5e). – Method A: from 4 and 0.02 mol 1-(tetrahydrofuran-2-yl)- me-
thylamine (2.02 g, 2.1 mL); reaction time 1 h. Method B: from 3 and 0.01 mol 1-(tetra-
hydrofuran-2-yl)-methylamine (1.01 g, 1.0 mL); reaction time 22 h.
Structures 5a–e were established by elemental analysis, FTIR and 1H NMR spectral
data (Tables I and II). The results were consistent with the assigned structures.
Pharmacology
Animals. – Male mice, strain H, mass 22–25 g, kept under standard conditions in an-
imal house (water and food ad libitum, 12 h dark and light cycle) were used throughout
the experiment. Controls were treated with the vehicle only (0.2% Tween 80 in saline), in
the same volume as treated animals (0.1 mL per 10 g b.m.). No effects were observed in
separate experiments to rule out the per se effect of the vehicle.
All experimental procedures described herein were in accordance with the NIH gui-
delines of the Care and Use of Laboratory animals.
Acute toxicity. – LD50 of the studied compounds was assessed by per oral and intra-
peritoneal route of administration. The tests were conducted according to the OECD TG
425 Up-And-Down Procedure (6).
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Spontaneous locomotor activity. – Spontaneous locomotor activity was measured in an
actometer (Activity Cage Ugo Basile, Italy). The animals (n = 6 per group) were intro-
duced into a chamber and their movements were quantified for 120 min at intervals of
20 min. The tested compounds were administered at a dose of 1/20 part of LD50, i.p., 30
min prior to the experiment. The results were compared to vehicle-treated animals.
Antihypoxic activity. – The tested compounds were administered at a dose of 1/20
part of LD50, i.p., 30 min prior to the experiment. Three models of provoked brain hy-
poxia were used. For asphyctic hypoxia 30 minutes after intraperitoneal administration,
mice (n = 8 per group) were placed into hermetic bottles of 200 cm3. Latency of hypoxic
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Table II. Spectral data of the synthesized compounds
Compd.
No.
IR (cm–1) (Nujol) 1H NMR (d, ppm) (DMSO-d6)
5a
3226 (NH), 3070 (CH – aromatic), 1704
(CO – xanthine), 1664 (CO – xanthine),
1645 with shoulders at 1608 and 1637
(CO – amide I, C=N, C=C – aromatic),
1558 and 1539 (C=C – xanthine, C=C –
aromatic), 755 and 746 (dCH – aromatic)
9.40 (s, 1H, NH), 7.18–6.98 (m, 3H,
aromatic ring), 3.78 (s, 6H, 2xOCH3),
3.60 (s, 2H, CH2), 3.55–3.50 (m, 2H,
CH2), 3.81, 3.61 and 3.31 (s, 3H, CH3),
2.80–2.76 (m, 2H, CH2)
5b
3274 (NH), 3100 (CH – aromatic), 1699
(CO – xanthine), 1661 with shoulders at
1605 and 1647 (CO – amide I, C=N, C=C
– aromatic), 1558 and 1539 (C=C – xan-
thine, C=C – aromatic, dNH – amide II),
754 and 746 (dCH – aromatic)
9.40 (s, 1H, NH), 7.08–6.95 (m, 5H,
aromatic ring), 3.65 (s, 2H, CH2),
3.55–3.50 (m, 2H, CH2), 3.78, 3.59 and
3.29 (s, 3H, CH3), 2.79–2.69 (m, 2H,
CH2)
5c
3271 (NH), 3063 (CH – aromatic), 1703
(CO – xanthine), 1699 (CO – xanthine),
1668 with shoulders at 1605 and 1634
(CO – amide I, C=C – aromatic), 1584 with
shoulders at 1557 and 1538 (C=C – aro-
matic, C=C – xanthine, dNH – amide II),
755 and 744 (dCH – aromatic)
9.40 (s, 1H, NH), 7.05–7.01 (m, 5H,
aromatic ring), 4.05–4.07 (m, 1H, CH),
3.90 (s, 2H, CH2), 3.79, 3.59 and 3.33
(s, 3H, CH3), 2.82–2.65 (m, 2H, CH2Ph),
1.30–1.20 (d, 3H, CH3)
5d
3348 (OH), 3279 (NH), 3086 (CH –
aromatic), 1699 with shoulder at 1703
(CO – xanthine), 1653, 1626 with
shoulder at 1605 (CO – amide I, C=C –
aromatic), 1562, 1537 and 1514 (C=C –
aromatic, C=C – xanthine, dNH – amide II),
748 (dCH – aromatic)
9.40 (s, 1H, NH), 7.11–6.95 (m, 4H,
aromatic ring), 3.77 (s, 2H, CH2),
3.66–3.46 (m, 2H, CH2), 3.65, 3.55 and
3.31 (s, 3H, CH3), 2.85–2.69 (m, 2H,
CH2)
5e
3262 (NH), 1701 (CO – xanthine), 1689
(CO – xanthine), 1665 with shoulders at
1605 and 1635 (CO – amide I, C=C –
aromatic), 1590 with shoulders at 1560
and 1542 (C=C – aromatic, C=C – xanthine,
dNH – amide II), 762 and 748 (sceletal vi-
brations)
9.40 (s, 1H, NH), 3.75 (s, 2H, CH2),
3.73–3.40 (m, 5H, 2xCH2, CH), 3.73,
3.52 and 3.29 (s, 3H, CH3), 1.95–1.20
(m, 6H, 3xCH2)
time (in min) was determined and compared with the control, vehicle-treated group (7).
For haemic hypoxia, 30 minutes after intraperitoneal administration of a compound, mice
(n = 8 per group) were intraperitonealy treated with NaNO2 (360 mg per kg–1 b.m.) and
antihypoxic activity was estimated in minutes as latent time evidencing hypoxia accord-
ing to the method of Roshtina and Ostrovskaya (8). For circulatory hypoxia, 30 minutes
after intraperitoneal administration of compounds, mice (n = 8 per group) were intra-
peritonealy treated with NaF (150 mg per kg–1 b.m.) and antihypoxic activity was esti-
mated in minutes as latent time of evidencing hypoxia (9).
Data analysis
The LD50 data were assessed by the AOT 425 statistical program (6). Locomotor ac-
tivity and antihypoxic activity were expressed as % of the control (vehicle treated) and
were compared by Student’s t-test.
RESULTS AND DISCUSSION
Chemistry
Caffeine-8-thioglycolamides were obtained from the corresponding amines by using
two synthetic approaches: aminolysis of methyl caffeine-8-thioglycolate (4) with amines
(Method A) and reaction with caffeine-8-thioglycolic acid (3) in the presence of carbodi-
imides (Method B).
The 8-substituted caffeine derivatives, described in this article, were synthesized as
outlined in Scheme 1.
A modified method of Persch and Beyerle (10) was used to synthesize caffeine-8-
-thioglycolic acid (3). The reaction was carried out in 60% ethanol and the yield was 92%.
Methyl caffeine-8-thioglycolate (4) was prepared by the method used for synthesizing
ethyl esters of 7-alkylxanthinyl-8-thioglycolic acids (11). The reaction was carried out in
anhydrous methanol in the presence of a catalytic amount of sulfuric or phosphoric acid
and the yield was 95%. After aminolysis of methyl caffeine-8-thioglycolate (4), com-
pounds 5a–e were obtained.
The second approach to obtaining the title compounds is also outlined in Scheme 1.
The process was carried out at the molar ratio of reactants 1:1:1 (acid/DCC/amine) at
room temperature in DMF. The reaction time varied between 20 and 24 h in dependence
on arylaliphatic amine used as the starting compound. The yields were about 10–20%.
The yields of 5a–e obtained by the carbodiimide method were lower than those obtained
by aminolysis of methyl caffeine-8-thioglycolate (4). These results can be explained by
the effects of the solvent on the reactivity of 3. It is known that in the carbodiimide me-
thod the increase in acid strength results in increased ester yield and shortening of the
reaction time (12). Since acetic acid exists predominantly in the monomeric form in polar
amphiprotic solvents (13, 14) it is assumed that in our case 3 in DMF manifests the same
tendency. Thus, De Tar and Silverstein (13, 14) claim that the presence of acid monomer
is responsible for the lower reactivity. On the other hand, DMF is a solvent with great
solvation properties and the existing acid monomer will be more solvated. In this case,
energy losses connected with acid desolvation must be of great importance.
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The IR spectra of the synthesised caffeine-8-thioglycolamides in the region 4000 to
400 cm–1 exhibit several characteristic bands. Thus, the three strong bands at 1660–1703
cm–1 are ascribable to streching vibratons of two carbonyl groups in the xanthine ring
and to streching vibraton of the amide carbonyl group (amide I band) in the side chain.
The band of bending vibration of the NH-group (amide II band) is in the 1590–1514 cm–1
region where streching vibrations of C4=C5 and C8=N9 bands of the xanthine ring ap-
pear, but it is more intensive. The intensive absorption band at 3279–3262 cm–1 corre-
sponds to streching vibrations of the NH-group in the side chain. In the spectrum of 5d,
a strong absorption band at 3348 cm–1 is ascribable to streching vibratons of the OH-
-group in the tyramine residue. Absorption bands at about 3100–3000 cm–1 are ascrib-
able to streching vibratons of C–H bonds in the aromatic ring, placed in the side chain as
phenethyl group.
The strong singlets at about 3.30, 3.60 and 3.80 ppm in the spectra (Table II) corre-
spond to N-methyl protons at positions 1, 3 and 7. The signal of the N-methylene group
from caffeine-8-thioglycolic acid at position 8 appears at 3.50–3.90 ppm as a broad sin-
glet. The signals of the other methylene protons and aromatic protons were observed
clearly in the spectra of 5a–d. The signals of methylene protons from the side chain of
5a–d form complicated multiplets at 1.20–2.85 and 3.40–3.73 ppm. The signals of methy-
ne protons from the side chain of 5c and 5e and the side chain methyl protons of 5c fell
in this region, which made a precise interpretation of the spectra difficult. However, the
integral curves correspond to the exact number of protons.
366
J. Mitkov et al.: Synthesis and brain antihypoxic activity of some aliphatic and arylaliphatic amides of caffeine-8-thioglycolic acid,















































































Compounds 5a–e are white crystals, insoluble in water and sparingly soluble in al-
cohols, but soluble in organic solvents such as chloroform, benzene, dimethylformamide
and dimethylsulfoxide.
Pharmacology
Tested compounds showed significantly (p < 0.05) lower toxicity than 1,3,7-trime-
thylxanthine (caffeine) (Table III). All compounds except 5c have acute toxicity of 5 g
kg–1 b.m. or more. The toxicity of compound 5d (> 5 g kg–1 b.m.) could be due to tyra-
mine substituent at position 8 in the side chain while the most toxic compound 5c (LD50
0.5–1 g kg–1 b.m.) has an amphetamine residue.
Compounds 5a,b,d,e were found to significantly suppress spontaneous locomotor
activity, while 5c significantly increased locomotion (Table IV).
Statistically significant antihypoxic activity of compound 5a was established in the
experimental model of haemic hypoxia while for compound 5b in the model of circula-
tory hypoxia (Table IV).
There are literature data that administration of sodium fluoride increases the blood
histamine content and decreases the oxygen carrying capacity (15). As known, hypoxia
causes significant changes in the activity of numerous intracellular enzymatic proteins.
Under the conditions of haemic hypoxia, a functional deficiency of the antioxidant sys-
tem and a high level of lipid peroxidation are observed, which contribute to maintaining
a labile state of the lysosomal membranes and activation of hydrolytic enzymes (16). In
our experiment, expressed antihypoxic activity of compound 5a in the haemic hypoxia
model could be partly explained by possible antioxidant properties of that compound.
This hypothesis remains to be elucidated in future experiments.
Caffeine is the most commonly ingested alkylxantine and is a recognized psycho-
stimulant. This compound improves some aspects of cognitive performance, but reduces
cerebral blood flow both in animals and humans. The decrease in cerebral blood flow is
produced at doses that increase cerebral glucose consumption. This is unlikely to be a
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5a 2750a > 5000a < 0.6
5b 3000a > 5000a < 0.6
5c 500a 1000a 0.5
5d > 5000a > 5000a 1
5e 1400a 4600a 0.3
Caffeine 369 527 0.7
a Statistically significant difference in comparison with caffeine (p  0.05).
IA (Index of Absorption) = LD50 (i.p.)/LD50 (p.o.).
beneficial profile of a drug to be used for the treatment of dementia of either neurodege-
nerative or vascular origin (16). In the model of circulatory hypoxia in our experiments,
caffeine expresses a slightly pro-hypoxy properties.
The study of Eun et al. (17) showed that preliminary acute treatment of mice with
the xanthine derivative pentoxyphylline increased cerebral blood flow and attenuated
hypoxic-ishemic brain injury in immature rats. The mechanism of this action is probably
due to the relaxation of brain blood vessels via the Ca2+ channel blocking activity and
some rheological properties.
Compounds 5a-d used in the study contain phenylethylamine residues. The pres-
ence of substituents in the carbohydrate side chain in compound 5c increases acute tox-
icity without alteration in antihypoxic activity. Antihypoxic activity is expressed in com-
pounds 5a (unsubstituted phenylethylamine fragment) and 5b (with two methoxy
groups in benzene ring). It seems that methoxy groups in the benzene ring do not influ-
ence acute toxicity. Compound 5d is devoid of antihypoxic activity and is practically
nontoxic. Structurally, it contains phenolic group in the benzene ring. More compounds
with different substituents on position 8 should be synthesized to determine the struc-
ture/activity relationship; as evident from our experiments, only compound 5b exhibits
a pronounced circulatory antihypoxic activity.
CONCLUSIONS
The most promising compounds are 5a (N-[2-(3,4-dimethoxyphenyl)-ethyl]-2-(1,3,7-
trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-acetamide) and 5b (N-phe-
nethyl-2-(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylsulfanyl)-acetamide).
They are practically non-toxic, impaired spontaneous locomotor activity and exhibited a
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Asphyctic hypoxia Haemic hypoxia Circulatory hypoxia
(min)b (%)a (min)b (%)a (min)b (%)a
Control 100  8 17.8  2.0 100 12.6  1.2 100 9.9  1.4 100
5a 137 33  7c 19.5  4.1 110 15.4  1.5c 123c 11.6  2.9 118
5b 150 14  2c 17.4  2.1 98 14.0  1.8 112 12.2  1.5c 124c
5c 25 117  7c 16.7  1.6 94 14.5  2.2 116 10.5  1.4 106
5d 250 39  4c 17.2  3.1 97 13.0  1.5 104 10.5  2.7 106
5e 70 47  5c 15.2  2.6 85 14.6  1.4 116 9.7  1.6 98
Caffeine 18 128  6c 17.7  4.2 99 13.2  1.4 95 9.1  1.4 94
a In comparison with control (vehicle only).
b Mean ± SD, n = 8.
c Statistically significant difference in comparison with control (p  0.05).
brain antihypoxic activity in models of haemic hypoxia (compound 5a) and circulatory
hypoxia (compound 5b). Further experiments will be done to assess the exact antihy-
poxic mechanism of action of compounds 5a and 5b.
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S A @ E T A K
Sinteza i antihipoksi~no djelovanje alifatskih i arilalifatskih amida
kofein-8-tioglikolne kiseline
JAVOR MITKOV, NIKOLAI DANCHEV, IRINA NIKOLOVA i ALEXANDER ZLATKOV
U radu je opisana sinteza alifatskih i arilalifatskih amida kofein-8-tioglikolne kise-
line i njihova karakterizacija elementarnom analizom, IR- i 1H NMR spektroskopijom.
Testiranja na mi{evima pokazuju da su sintetizirani spojevi primijenjeni p.o. i i.p. manje
toksi~ni od kofeina. Smanjenje lokomotori~ke aktivnosti podupire ideju o njihovom de-
presivnom djelovanju na S@S. Spojevi 5a i 5b djeluju antihipoksi~ki u uvjetima krvne i
cirkulacijske hipoksije u mozgu.
Klju~ne rije~i: kofein-8-tioglikolna kiselina, alifatski i arilalifatski amidi, antihipoksi~no djelovanje u
mozgu, akutna toksi~nost
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